ITT Operating Cash Flow decreased by 82.5% to $39.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 64.8%, from $113.40M to $39.90M. Over 3 years (FY 2022 to FY 2025), Operating Cash Flow shows an upward trend with a 34.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$302.40M | -$2.70M | $56.90M | $61.00M | $162.50M | $58.10M | $139.70M | $169.80M | $170.40M | $57.80M | $157.70M | $123.90M | $223.20M | $113.40M | $153.70M | $173.90M | $227.80M | $39.90M |
| QoQ Change | — | +99.1% | >999% | +7.2% | +166.4% | -64.2% | +140.4% | +21.5% | +0.4% | -66.1% | +172.8% | -21.4% | +80.1% | -49.2% | +35.5% | +13.1% | +31.0% | -82.5% |
| YoY Change | — | — | +118.8% | — | — | >999% | +145.5% | +178.4% | +4.9% | -0.5% | +12.9% | -27.0% | +31.0% | +96.2% | -2.5% | +40.4% | +2.1% | -64.8% |